View in EDS HTML Full Text PDF Full Text

Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

Saved in:
Bibliographic Details
Title: Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Authors: Amat‐Santos, Ignacio J.1,2 (AUTHOR), Sánchez‐Luna, Juan P.1,2 (AUTHOR), Abu‐Assi, Emad3 (AUTHOR), Melendo‐Viu, María3 (AUTHOR), Cruz‐Gonzalez, Ignacio4 (AUTHOR), Nombela‐Franco, Luis5 (AUTHOR), Muñoz‐Garcí, Antonio J.1,6 (AUTHOR), Blas, Sergio G.7 (AUTHOR), de la Torre Hernandez, Jose M.8 (AUTHOR), Romaguera, Rafael9 (AUTHOR), Sánchez‐Recalde, Ángel10 (AUTHOR), Diez‐Gil, José L.11 (AUTHOR), Lopez‐Otero, Diego1,12 (AUTHOR), Gheorge, Livia13 (AUTHOR), Ibáñez, Borja1,14,15 (AUTHOR), Iñiguez‐Romo, Andrés3 (AUTHOR), Raposeiras‐Roubín, Sergio3,15 (AUTHOR) raposeiras26@hotmail.com, Muñoz‐García, Erika (AUTHOR), Sanz‐Sánchez, Jorge (AUTHOR), Pereiro‐Montes, Diana (AUTHOR)
Source: European Journal of Heart Failure. Mar2022, Vol. 24 Issue 3, p581-588. 8p. 2 Diagrams, 3 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.2370